The worthlessness of Vitamin D is mildly exaggerated

Sunlight vs. supplements

• Several comments note that sunlight exposure shows much larger reductions in all‑cause mortality (~30%) than vitamin D pills in trials.
• Hypothesis: blood vitamin D is mainly a marker for outdoor time, exercise, and other sunlight effects (e.g., nitric oxide, “red light therapy”), not the causal agent by itself.
• Some argue you can’t simply replace complex sun‑exposure pathways with a single oral supplement.

Deficiency vs. general supplementation

• Strongest evidence in the thread: correcting severe deficiency (e.g., rickets‑range or very low lab values) is clearly beneficial.
• For people with “normal-ish” levels, RCTs show small or no mortality benefits from standard-dose supplementation.
• Some commenters emphasize the original article focuses on mortality, not quality of life, where many report perceived benefits.

Cofactors: K2 and magnesium

• Many report that D3 alone did little, but D3+K2 or D3+magnesium normalized their levels or symptoms.
• K2 is discussed as steering calcium to bones instead of arteries and possibly mitigating high‑dose D risks, though solid RCTs on D3+K2 are noted as lacking.
• Magnesium is cited as important for vitamin D activation; deficiency may blunt D’s effect.

Dosage, labs, and safety

• Personal regimens range from 1,000 IU to 10,000 IU/day; responses vary widely.
• Several people on 2,000 IU remained deficient and needed 4,000–5,000 IU; others found 10,000 IU pushed them toward excess.
• Repeated advice: use blood tests (25‑OH D) and adjust dose rather than “flying blind”; vitamin D accumulates and steady-state levels change slowly.
• Some report toxicity or feeling unwell after over‑supplementing; others see more excess than deficiency in current practice.

Latitude, skin color, and prevalence

• Data from a Belgian lab and northern European anecdotes suggest mass deficiency at the end of winter; commenters in Germany say deficiency is “basically the norm.”
• Darker‑skinned people in high latitudes or migration contexts are repeatedly mentioned as at higher risk, though some question whether they need the same reference ranges.

Anecdotes vs. evidence and meta‑skepticism

• Many report dramatic improvements in mood, muscle pain, infections, arrhythmia, or “winter blues” after correcting low D (often with K2/Mg), while others note no subjective change despite higher levels.
• Some attribute benefits to placebo or to confounders (more outdoor time, overall lifestyle changes).
• There is criticism of supplement hype, weak observational correlations, and overinterpretation; others push back, stressing cheap tests and low risk when guided by labs.
• A physician warns against relying on HN for health advice; others counter that distrust of healthcare systems pushes people toward self‑experimentation.